Gene Therapy for Rare Disorders
February 22-25, 2021
FUJIFILM Diosynth Biotechnologies is excited to be attending the 4th Annual Gene Therapy for Rare Disorders virtual conference on February 22-25, 2021. Connect with the Commercial Development team to learn more about our capabilities and how we could help you advance and deliver tomorrow’s medicines.
Tune in on February 23, 2021 at 3pm to the CMC & Analytic track
Thomas Page, VP of Engineering & Asset Development, FUJIFILM Diosynth Biotechnologies, College Station, TX will be part of a panel discussion:
Title: Understanding Manufacturing and CMC Parameters that Require Standardization
- Reducing variability of assays – what approaches are involved
- Updating historically variable assays such as the TCID50 infectivity assay – what alternatives are there?
- Investigating automation as an approach to reduce variability
For the complete agenda and registration please visit Gene Therapy for Rare Disorders